Mitsubishi Gas Chemical Company (4182) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
16 Feb, 2026Executive summary
Net sales increased 0.6% year-over-year to ¥188.1 billion, driven by yen depreciation and higher sales of optical polymers and electronic materials, despite the transition of JSP Corporation to an equity-method affiliate.
Operating profit rose sharply by 153.3% to ¥15.7 billion, supported by higher sales volumes in semiconductor-related products, cost improvements, and favorable forex effects.
Ordinary profit increased to ¥17.95 billion, aided by higher methanol prices and improved equity in earnings of affiliates.
Profit attributable to owners of parent declined 40.9% year-over-year to ¥11.73 billion due to the absence of prior year’s one-time gain from step acquisitions.
Financial highlights
Net sales: ¥188.1 billion (+0.6% YoY).
Operating profit: ¥15.7 billion (+153.3% YoY).
Ordinary profit: ¥17.95 billion (+155.6% YoY).
EPS: ¥58.60 (down from ¥97.00 YoY).
Gross profit increased to ¥43.2 billion from ¥37.6 billion YoY.
Comprehensive income decreased 14.2% YoY to ¥27.3 billion.
Total assets grew to ¥1,093.3 billion as of June 30, 2024, with an equity ratio of 61.6%.
Outlook and guidance
FY2024 full-year net sales forecast revised to ¥790.0 billion, operating profit to ¥54.0 billion, and profit attributable to owners of parent to ¥48.0 billion.
Operating profit projected at ¥54 billion (up 14.1%), ordinary profit at ¥62 billion (up 34.7%).
Annual dividend forecast raised to ¥90 per share.
2Q net sales expected at ¥201.8 billion (+7.3% QoQ), with operating profit forecast to decrease to ¥12.2 billion (-22.0% QoQ).
2H net sales revised down by ¥10.0 billion due to LNG sales timing; operating and ordinary profit unchanged.
FX assumptions: $1 = ¥150, €1 = ¥160; crude oil at $80/bbl.
Latest events from Mitsubishi Gas Chemical Company
- Operating profit surged 52.7% year-over-year, driven by Specialty Chemicals growth.4182
Q2 202516 Feb 2026 - Operating profit rose 17.2% despite lower sales, driven by Specialty Chemicals and yen effects.4182
Q3 202516 Feb 2026 - Operating profit up 7.4% despite 4.9% sales drop; FY2025 outlook cautious.4182
Q4 202516 Feb 2026 - Profits fell on weak chemical markets and FX volatility, but sales forecast was raised.4182
Q1 202616 Feb 2026 - Profits fell on lower prices and impairments, but dividend forecast raised to ¥100 per share.4182
Q3 202616 Feb 2026 - Impairment loss and weak markets drive lower profits and a revised net loss outlook for FY2025.4182
Q2 202616 Feb 2026